HEADER TRANSFERASE 01-JUN-00 1F3B TITLE CRYSTAL STRUCTURE OF MGSTA1-1 IN COMPLEX WITH GLUTATHIONE CONJUGATE OF TITLE 2 BENZO[A]PYRENE EPOXIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTATHIONE S-TRANSFERASE YA CHAIN; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.5.1.18; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET-11D KEYWDS GLUTATHIONE S-TRANSFERASE, GST, BPDE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.GU,S.V.SINGH,X.JI REVDAT 7 13-NOV-24 1F3B 1 REMARK REVDAT 6 15-NOV-23 1F3B 1 REMARK REVDAT 5 30-AUG-23 1F3B 1 AUTHOR JRNL REMARK SEQADV REVDAT 5 2 1 LINK REVDAT 4 04-OCT-17 1F3B 1 REMARK REVDAT 3 24-FEB-09 1F3B 1 VERSN REVDAT 2 01-APR-03 1F3B 1 JRNL REVDAT 1 18-OCT-00 1F3B 0 JRNL AUTH Y.GU,S.V.SINGH,X.JI JRNL TITL RESIDUE R216 AND CATALYTIC EFFICIENCY OF A MURINE CLASS JRNL TITL 2 ALPHA GLUTATHIONE S-TRANSFERASE TOWARD BENZO[A]PYRENE JRNL TITL 3 7(R),8(S)-DIOL 9(S), 10(R)-EPOXIDE. JRNL REF BIOCHEMISTRY V. 39 12552 2000 JRNL REFN ISSN 0006-2960 JRNL PMID 11027134 JRNL DOI 10.1021/BI001396U REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH B.XIAO,S.P.SINGH,B.NANDURI,Y.C.AWASTHI,P.ZIMNIAK,X.JI REMARK 1 TITL CRYSTAL STRUCTURE OF A MURINE GLUTATHIONE S-TRANSFERASE IN REMARK 1 TITL 2 COMPLEX WITH A GLUTATHIONE CONJUGATE OF 4-HYDROXYNON-2-ENAL REMARK 1 TITL 3 IN ONE SUBUNIT AND GLUTATHIONE IN THE OTHER: EVIDENCE OF REMARK 1 TITL 4 SIGNALING ACROSS THE DIMER INTERFACE REMARK 1 REF BIOCHEMISTRY V. 38 11887 1999 REMARK 1 REFN ISSN 0006-2960 REMARK 1 DOI 10.1021/BI990468I REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.1 REMARK 3 NUMBER OF REFLECTIONS : 29606 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1543 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3584 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 86 REMARK 3 SOLVENT ATOMS : 524 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.014 REMARK 3 BOND ANGLES (DEGREES) : 1.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1F3B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-JUN-00. REMARK 100 THE DEPOSITION ID IS D_1000011191. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-APR-99 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X9B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0087 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31332 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 3.150 REMARK 200 R MERGE (I) : 0.13300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.0500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.48000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, ISOPROPANOL, HEPES, PH 7.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 288K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 49.65150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.81850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 49.65150 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 46.81850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5850 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20260 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 823 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 821 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 822 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 825 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 12 -73.63 -60.78 REMARK 500 LYS A 63 75.72 -115.55 REMARK 500 GLN A 66 109.59 76.74 REMARK 500 ASP A 170 104.53 -165.09 REMARK 500 LYS A 220 96.73 46.41 REMARK 500 ARG B 12 -74.08 -64.77 REMARK 500 LYS B 63 78.37 -113.04 REMARK 500 GLN B 66 111.73 80.98 REMARK 500 PRO B 113 -36.53 -37.86 REMARK 500 ASP B 170 103.32 -166.06 REMARK 500 ARG B 216 14.53 -61.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GBX A 223 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GBX B 224 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1B48 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MGSTA4-4 IN COMPLEX WITH GSH CONJUGATE OF 4- REMARK 900 HYDROXYNONENAL IN ONE SUBUNIT AND GSH IN THE OTHER REMARK 900 RELATED ID: 1F3A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MGSTA1-1 IN COMPLEX WITH GSH DBREF 1F3B A 1 222 UNP P13745 GSTA1_MOUSE 1 222 DBREF 1F3B B 1 222 UNP P13745 GSTA1_MOUSE 1 222 SEQADV 1F3B CSO A 111 UNP P13745 CYS 111 MODIFIED RESIDUE SEQADV 1F3B CSO B 111 UNP P13745 CYS 111 MODIFIED RESIDUE SEQRES 1 A 222 ALA GLY LYS PRO VAL LEU HIS TYR PHE ASN ALA ARG GLY SEQRES 2 A 222 ARG MET GLU CYS ILE ARG TRP LEU LEU ALA ALA ALA GLY SEQRES 3 A 222 VAL GLU PHE GLU GLU LYS PHE ILE GLN SER PRO GLU ASP SEQRES 4 A 222 LEU GLU LYS LEU LYS LYS ASP GLY ASN LEU MET PHE ASP SEQRES 5 A 222 GLN VAL PRO MET VAL GLU ILE ASP GLY MET LYS LEU ALA SEQRES 6 A 222 GLN THR ARG ALA ILE LEU ASN TYR ILE ALA THR LYS TYR SEQRES 7 A 222 ASP LEU TYR GLY LYS ASP MET LYS GLU ARG ALA LEU ILE SEQRES 8 A 222 ASP MET TYR SER GLU GLY ILE LEU ASP LEU THR GLU MET SEQRES 9 A 222 ILE GLY GLN LEU VAL LEU CSO PRO PRO ASP GLN ARG GLU SEQRES 10 A 222 ALA LYS THR ALA LEU ALA LYS ASP ARG THR LYS ASN ARG SEQRES 11 A 222 TYR LEU PRO ALA PHE GLU LYS VAL LEU LYS SER HIS GLY SEQRES 12 A 222 GLN ASP TYR LEU VAL GLY ASN ARG LEU THR ARG VAL ASP SEQRES 13 A 222 ILE HIS LEU LEU GLU VAL LEU LEU TYR VAL GLU GLU PHE SEQRES 14 A 222 ASP ALA SER LEU LEU THR PRO PHE PRO LEU LEU LYS ALA SEQRES 15 A 222 PHE LYS SER ARG ILE SER SER LEU PRO ASN VAL LYS LYS SEQRES 16 A 222 PHE LEU GLN PRO GLY SER GLN ARG LYS PRO PRO MET ASP SEQRES 17 A 222 ALA LYS GLN ILE GLN GLU ALA ARG LYS ALA PHE LYS ILE SEQRES 18 A 222 GLN SEQRES 1 B 222 ALA GLY LYS PRO VAL LEU HIS TYR PHE ASN ALA ARG GLY SEQRES 2 B 222 ARG MET GLU CYS ILE ARG TRP LEU LEU ALA ALA ALA GLY SEQRES 3 B 222 VAL GLU PHE GLU GLU LYS PHE ILE GLN SER PRO GLU ASP SEQRES 4 B 222 LEU GLU LYS LEU LYS LYS ASP GLY ASN LEU MET PHE ASP SEQRES 5 B 222 GLN VAL PRO MET VAL GLU ILE ASP GLY MET LYS LEU ALA SEQRES 6 B 222 GLN THR ARG ALA ILE LEU ASN TYR ILE ALA THR LYS TYR SEQRES 7 B 222 ASP LEU TYR GLY LYS ASP MET LYS GLU ARG ALA LEU ILE SEQRES 8 B 222 ASP MET TYR SER GLU GLY ILE LEU ASP LEU THR GLU MET SEQRES 9 B 222 ILE GLY GLN LEU VAL LEU CSO PRO PRO ASP GLN ARG GLU SEQRES 10 B 222 ALA LYS THR ALA LEU ALA LYS ASP ARG THR LYS ASN ARG SEQRES 11 B 222 TYR LEU PRO ALA PHE GLU LYS VAL LEU LYS SER HIS GLY SEQRES 12 B 222 GLN ASP TYR LEU VAL GLY ASN ARG LEU THR ARG VAL ASP SEQRES 13 B 222 ILE HIS LEU LEU GLU VAL LEU LEU TYR VAL GLU GLU PHE SEQRES 14 B 222 ASP ALA SER LEU LEU THR PRO PHE PRO LEU LEU LYS ALA SEQRES 15 B 222 PHE LYS SER ARG ILE SER SER LEU PRO ASN VAL LYS LYS SEQRES 16 B 222 PHE LEU GLN PRO GLY SER GLN ARG LYS PRO PRO MET ASP SEQRES 17 B 222 ALA LYS GLN ILE GLN GLU ALA ARG LYS ALA PHE LYS ILE SEQRES 18 B 222 GLN MODRES 1F3B CSO A 111 CYS S-HYDROXYCYSTEINE MODRES 1F3B CSO B 111 CYS S-HYDROXYCYSTEINE HET CSO A 111 7 HET CSO B 111 7 HET GBX A 223 43 HET GBX B 224 43 HETNAM CSO S-HYDROXYCYSTEINE HETNAM GBX 2-AMINO-4-[1-(CARBOXYMETHYL-CARBAMOYL)-2-(9-HYDROXY-7, HETNAM 2 GBX 8-DIOXO-7,8,9,10-TETRAHYDRO-BENZO[DEF]CHRYSEN-10- HETNAM 3 GBX YLSULFANYL)-ETHYLCARBAMOYL]-BUTYRIC ACID HETSYN GBX GLUTATHIONE CONJUGATE OF (+)-ANTI-BPDE FORMUL 1 CSO 2(C3 H7 N O3 S) FORMUL 3 GBX 2(C30 H27 N3 O9 S) FORMUL 5 HOH *524(H2 O) HELIX 1 1 MET A 15 ALA A 25 1 11 HELIX 2 2 SER A 36 ASP A 46 1 11 HELIX 3 3 GLN A 66 TYR A 78 1 13 HELIX 4 4 ASP A 84 GLN A 107 1 24 HELIX 5 5 LEU A 108 LEU A 110 5 3 HELIX 6 6 PRO A 112 ARG A 130 1 19 HELIX 7 7 ARG A 130 GLY A 143 1 14 HELIX 8 8 THR A 153 ASP A 170 1 18 HELIX 9 9 ALA A 171 LEU A 174 5 4 HELIX 10 10 PHE A 177 SER A 189 1 13 HELIX 11 11 LEU A 190 GLN A 198 1 9 HELIX 12 12 ASP A 208 LYS A 220 1 13 HELIX 13 13 MET B 15 GLY B 26 1 12 HELIX 14 14 SER B 36 ASP B 46 1 11 HELIX 15 15 GLN B 66 TYR B 78 1 13 HELIX 16 16 ASP B 84 LEU B 108 1 25 HELIX 17 17 PRO B 112 ARG B 130 1 19 HELIX 18 18 ARG B 130 GLY B 143 1 14 HELIX 19 19 THR B 153 ASP B 170 1 18 HELIX 20 20 ALA B 171 LEU B 174 5 4 HELIX 21 21 PHE B 177 SER B 189 1 13 HELIX 22 22 LEU B 190 GLN B 198 1 9 HELIX 23 23 ASP B 208 PHE B 219 1 12 SHEET 1 A 4 GLU A 30 ILE A 34 0 SHEET 2 A 4 VAL A 5 PHE A 9 1 N LEU A 6 O GLU A 30 SHEET 3 A 4 MET A 56 ILE A 59 -1 O MET A 56 N HIS A 7 SHEET 4 A 4 MET A 62 ALA A 65 -1 N MET A 62 O ILE A 59 SHEET 1 B 4 GLU B 30 ILE B 34 0 SHEET 2 B 4 VAL B 5 PHE B 9 1 N LEU B 6 O GLU B 30 SHEET 3 B 4 MET B 56 ILE B 59 -1 O MET B 56 N HIS B 7 SHEET 4 B 4 MET B 62 ALA B 65 -1 N MET B 62 O ILE B 59 LINK C LEU A 110 N CSO A 111 1555 1555 1.32 LINK C CSO A 111 N PRO A 112 1555 1555 1.35 LINK C LEU B 110 N CSO B 111 1555 1555 1.33 LINK C CSO B 111 N PRO B 112 1555 1555 1.35 CISPEP 1 VAL A 54 PRO A 55 0 0.30 CISPEP 2 VAL B 54 PRO B 55 0 1.35 SITE 1 AC1 22 TYR A 8 PHE A 9 ARG A 14 LYS A 44 SITE 2 AC1 22 ASP A 52 GLN A 53 VAL A 54 GLN A 66 SITE 3 AC1 22 THR A 67 ALA A 215 ARG A 216 PHE A 219 SITE 4 AC1 22 ILE A 221 HOH A 405 HOH A 442 HOH A 546 SITE 5 AC1 22 HOH A 685 HOH A 776 HOH A 814 ASP B 100 SITE 6 AC1 22 ARG B 130 HOH B 331 SITE 1 AC2 23 ASP A 100 ARG A 130 HOH A 352 TYR B 8 SITE 2 AC2 23 PHE B 9 ARG B 14 LYS B 44 GLN B 53 SITE 3 AC2 23 VAL B 54 PRO B 55 GLN B 66 THR B 67 SITE 4 AC2 23 ALA B 215 ARG B 216 PHE B 219 ILE B 221 SITE 5 AC2 23 HOH B 338 HOH B 389 HOH B 432 HOH B 538 SITE 6 AC2 23 HOH B 681 HOH B 784 HOH B 812 CRYST1 99.303 93.637 52.217 90.00 91.80 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010070 0.000000 0.000317 0.00000 SCALE2 0.000000 0.010680 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019160 0.00000